Wockhardt is reportedly planning to sell four residual hospitals located outside Mumbai. The company has hired a Chennai-based investment bank to get buyer for the assets.
The company will offload other hospitals and planning to keep the Mumbai assets with them. The company is planning to sell properties in Rajkot, Nashik and Nagpur.
Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.
